News

The European Commission has recently published the MIR 7.3.1 form, which will be required to use from November 2025 for (...)

Team-NB published an updated version of its Position Paper on the European Artificial Intelligence Act. It aims to present its (...)

The Team-NB Position Paper on the certification process under Regulation (EU) 2017/746 aims to provide a harmonized and detailed framework (...)

In this video, Tom Patten, GMED International IVDR Manager, covers some of the upcoming crucial dates for IVD manufacturers, including: May 26, (...)

Team-NB published an updated version of its Position Paper “Best practice guidance for the submission of technical documentation under Annex (...)

GMED will be at the MedTech Forum, Europe’s leading healthcare and medical technology conference. Come meet our team at booth (...)

The Medical Device Coordination Group has just published the 4th revision of the MDCG 2020-16 guidance on the classification rules (...)

Regulation (EU) 2025/327 on the European Health Data Space (#EHDS) and amending Directive 2011/24/EU and Regulation (EU) 2024/2847 was published (...)

In February 2025, the European Commission, after consultation with the Member States in the Medical Device Coordination Group (MDCG), launched (...)

GMED North America is hosting a RAPS DC/Baltimore Chapter in-person event on June 5, 2025, between 4:30 and 7:00 p.m. (...)

This newsletter from the European Commission aims to provide highlights and updates from the medical devices and in vitro diagnostic (...)

GMED will be back at RAPS Euro Convergence in 2025! From May 14-15 in Brussels (Belgium), join Béatrice Lys, Technical (...)

The EMA has updated its Q&A guidance on the implementation of EU regulations for medical devices and in vitro diagnostic medical (...)

The Medical Device Coordination Group (MDCG) has published an update to its Q&A related to notified bodies’ requirements under MDR (...)

The annual revision of the EMDN ensures that MD nomenclature incorporates the latest innovations, ensuring accurate classification. These updates ensure (...)

From Paris to Washington D.C., via London and Hong Kong, all our teams would like to thank you for the (...)

The MDCG has just published a form for manufacturers to report interruptions or discontinuation of the supply of certain IVDs (...)

The European Commission has published a Q&A on practical aspects related to the implementation of the gradual roll-out of Eudamed (...)

The European Commission has launched a public consultation and call for evidence on the European Regulation on medical devices and (...)

In November 2024, the MDCG published a revision of the several questions listed in its Q&A on vigilance terms and (...)

The European Commission has published a Q&A on the practical aspects related to the implementation of the obligations, laid down (...)

The MDCG has published a guide concerning the qualification of ethylene oxide (EtO) which led to the update of the (...)

GMED will be attending MedFIT from December 3 to 4 at Lille and from December 11 to 12 for online (...)

A new draft statutory instrument for post-marketing surveillance has been published. Our team has conducted a detailed gap analysis to (...)

This newsletter from the European Commission aims to provide highlights and updates from the medical devices and in vitro diagnostic (...)

The guidance MDCG 2021-25 on the application of the MDR requirements to ‘legacy devices’ has been updated in order to (...)

On October 8, 2024, the MDCG published a guidance that clarifies what products fall in the scope of Regulation (UE) 2017/746 (...)

The Commission Implementing Decisions (EU) 2024/2631 and (EU) 2024/2625 have been published in the Official Journal of the European Union (...)

We are delighted to announce the launch of our new format, GMED Highlights. Every month, GMED Highlights brings you a (...)

GMED, a subsidiary of the LNE group, is expanding its certification business with the creation of GMED Asia, based in (...)